Atrial Fibrillation Recurrent: Clinical Trials

1 trial for Atrial Fibrillation Recurrent, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Atrial Fibrillation Recurrent: new trials by email Literature Review of Atrial Fibrillation Recurrent trials Research Report on Atrial Fibrillation Recurrent

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence
dronedarone 400 mg Oral Tablet, Placebo - Atrial Fibrillation, Atrial Fibrillation Recurrent
Phase 4TerminatedTulane University School of Medicine222021-05-152025-10-30

Narrower conditions

Arrhythmias, Cardiac (1)  ·  Atrial Fibrillation (1)  ·  Heart Murmurs (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Dronedarone (1)  ·  Tablets (1)

Sponsors

Tulane University School of Medicine (1)

Countries

United States (1)

Top investigators

Nassir F Marrouche, MD (1)

Results publications

PMID 34664772